tiprankstipranks
23andMe Holding Executive Resigns, Therapeutics Division Closes
Company Announcements

23andMe Holding Executive Resigns, Therapeutics Division Closes

Stay Ahead of the Market:

23andMe Holding (ME) has provided an announcement.

Bill Richards, a key executive at a company, is set to resign on August 23, 2024, with a severance package including half a year’s salary, healthcare benefits, and accelerated stock vesting. Concurrently, the company is shutting down its Therapeutics Discovery division as of August 9, 2024, which will lead to 30 layoffs, though they anticipate no significant financial repercussions. The remaining Therapeutics segment will focus on advancing its clinical development programs.

See more insights into ME stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App